← Back to headlines
Immunome's Chief Scientist Trims Stake Ahead of Planned FDA Submission
Immunome's Chief Scientist has reduced his stake in the company, a move that comes ahead of a planned FDA submission, suggesting potential implications for the company's future.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Amazon's First Customer Receipt Goes Viral, Bezos and Musk React
just now
Four Arrested for Selling P102 Million in Counterfeit Anti-Cancer Medicine in Makati
just now
Philippines receives diesel shipment from Malaysia
just now
Frozen Fish Initiative Reaches 50 Cities as Morocco Plans Permanent Network
15m ago